OPCH Stock Analysis: Buy, Sell, or Hold?
OPCH - Option Care Health, Inc. Common Stock
$23.86
0.83 (3.60%)
▲
5d:
+9.4%
30d:
+8.95%
90d:
+19.12%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jul 29, 2026
0d
Get Alerted When OPCH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: OPCH shows positive signals but monitor for confirmation. Market pricing in 6.9% decline. Moderate conviction.
💡 BUY OPPORTUNITY: OPCH shows positive signals but monitor for confirmation. Market pricing in 6.9% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$39.62
Based on 6.8% avg growth
INTRINSIC VALUE TODAY
$24.60
3.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OPCH is currently trading at $23.86, which is considered extended relative to its 30-day fair value range of $21.12 to $22.59. From a valuation perspective, the stock is trading at a discount (Forward PE: 11.2) compared to its historical average (13.9). Remarkably, the market is currently pricing in an annual earnings decline of 6.9% over the next few years. This pessimistic expectation contrasts with the company's recent 12.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, OPCH is in a strong downtrend. Immediate support is located at $20.68, while resistance sits at $24.96. The stock is showing strong short-term momentum, up 3.6% recently.
Market Sentiment: OPCH has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $28.42 (+23.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, OPCH is in a strong downtrend. Immediate support is located at $20.68, while resistance sits at $24.96. The stock is showing strong short-term momentum, up 3.6% recently.
Market Sentiment: OPCH has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $28.42 (+23.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$21.12 -
$22.59
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range (+5.6% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.6%)
- BULLISH: Trading 23.4% below Wall St target ($28.42)
Trading Range Analysis
30-Day Trading Range
$21.12 -
$22.59
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$20.68
Resistance Level
$24.96
Current Trend
Strong Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.19
Wall Street Target
$28.42
(+23.4%)
Revenue Growth (YoY)
1.9%
Earnings Growth (YoY)
12.9%
Profit Margin
3.7%
Valuation Discount vs History
-6.9% cheaper
PE vs Historical
11.2 vs 13.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.9%
(market-implied from PE analysis)
1-Year Target
$21.44
(-7%)
2-Year Target
$19.96
(-13%)
3-Year Target
$18.58
(-19%)
3-Yr Target (if PE normalizes)
(PE: 11→14)
$23.08
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 9.5%)
$56.06
(+143%)
Base:
(SPY PE: 11.2, Growth: 9.5%)
$30.26
(+31%)
Bear:
(PE: 9.5, Growth: 9.5%)
$25.72
(+12%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (17x PE), but valuation improves significantly next year (11x PE) as earnings recover.
Trailing PE: 17.02 | Current EPS (TTM): $1.32
Bull Case
$38.52
(+67%)
Analyst growth 55.9%, PE expands to 18.7
Base Case
$35.02
(+52%)
Market implied 55.9%, PE stable at 17.0
Bear Case
$15.27
(-34%)
Severe decline -20.0%, PE contracts to 14.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 11.2 to 13.9
Stabilization Target:
$28.60
(+24.2%)
PE Expansion Potential:
+24.2%
Share & Embed Analysis
Last updated: August 03, 2026 2:25 PM ET
Data refreshes hourly during market hours. Next update: 3:25 PM
Data refreshes hourly during market hours. Next update: 3:25 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OPCH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$277 | 52 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$453 | 47 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 46 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 47 HOLD |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$33 | 61 BUY |
